Trials / Completed
CompletedNCT06373835
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Emodepside and in Comparison to Ivermectin Against Strongyloidiasis Stercoralis in Adults: Randomized Stage II Seamless Adaptive Controlled Trials
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- Swiss Tropical & Public Health Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy, safety and pharmacokinetics of ascending dosages of emodepside and in comparison to ivermectin against Strongyloidiasis stercoralis in adults: randomized stage II seamless adaptive controlled trials
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Emodepside | 5 mg tablets of emodepside and matching placebo tablets, 3mg ivermectin |
Timeline
- Start date
- 2024-05-20
- Primary completion
- 2024-09-21
- Completion
- 2024-09-21
- First posted
- 2024-04-18
- Last updated
- 2024-11-20
Locations
1 site across 1 country: Laos
Source: ClinicalTrials.gov record NCT06373835. Inclusion in this directory is not an endorsement.